rethinkPeptides Search
Menu
Home / Research library
Study breakdown

BNP Blood Levels Predict Outcomes Better Than ANP in Chronic Heart Failure Patients

RPEP-004351997Tsutamoto, T; Wada, A; Maeda, K; Hisanaga, T; Maeda, Y; Fukai, D; Ohnishi, M; Sugimoto, Y; Kinoshita, M
CohortStrong evidence
The takeaway

Plasma BNP concentration provides superior prognostic value in chronic heart failure compared to ANP and other established variables, predicting outcomes in symptomatic left ventricular dysfunction.

BNP: best prognostic marker

BNP outperformed ANP and other established variables for predicting outcomes in chronic heart failure

What the researchers found

Plasma BNP concentration provided superior prognostic value compared to plasma ANP and other established variables in chronic symptomatic left ventricular dysfunction.

Why it matters

Better prognostic markers help clinicians identify high-risk heart failure patients who need more aggressive treatment, potentially saving lives through earlier intervention.

How the study worked

Cohort study comparing plasma BNP and ANP as prognostic markers in patients with chronic symptomatic CHF alongside other established prognostic variables.

What this study cannot tell us

Cohort study; specific outcome endpoints, follow-up duration, and sample size not detailed in abstract.

How to read the evidence

Strong clinical evidence from a prognostic cohort study comparing multiple biomarkers and risk variables.

When this study was published

Published in 1997, this study contributed to BNP becoming the gold standard prognostic biomarker in heart failure.

The bigger picture

This study was instrumental in establishing BNP as the standard prognostic biomarker in heart failure, now used worldwide to guide treatment intensity.

Questions still open

  • What BNP cutoff values best stratify heart failure prognosis?
  • Can serial BNP measurements guide treatment adjustments in real time?

Common questions

Why is BNP better than ANP for prognosis?
BNP comes mainly from the ventricles — the heart's main pumping chambers. As heart failure worsens, the ventricles are most affected, so BNP rises proportionally more than ANP (which comes mainly from the atria). This makes BNP a more direct measure of how much the heart is struggling.
How is BNP used in clinical practice?
Doctors measure BNP to determine heart failure severity, predict patient outcomes, and guide treatment intensity. Higher BNP levels trigger more aggressive therapy, while declining levels indicate treatment is working.

Read the original research

Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction.

Circulation, 96(2), 509-16

View on PubMed ↗

Citation

Tsutamoto, T; Wada, A; Maeda, K; Hisanaga, T; Maeda, Y; Fukai, D; Ohnishi, M; Sugimoto, Y; Kinoshita, M. (1997). Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction.. Circulation, 96(2), 509-16.